Clarity Pharmaceuticals Ltd banner
C

Clarity Pharmaceuticals Ltd
ASX:CU6

Watchlist Manager
Clarity Pharmaceuticals Ltd
ASX:CU6
Watchlist
Price: 3.08 AUD -5.52% Market Closed
Market Cap: AU$1.1B

Intrinsic Value

The intrinsic value of one CU6 stock under the Base Case scenario is 0.6 AUD. Compared to the current market price of 3.08 AUD, Clarity Pharmaceuticals Ltd is Overvalued by 81%.

CU6 Intrinsic Value
0.6 AUD
Overvaluation 81%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
Clarity Pharmaceuticals Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about CU6?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CU6 valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Clarity Pharmaceuticals Ltd.

Explain Valuation
Compare CU6 to

Fundamental Analysis

Financials

Revenue & Expenses Breakdown
Clarity Pharmaceuticals Ltd

Efficiency

Earnings Waterfall
Clarity Pharmaceuticals Ltd

Wall St
Price Targets

Dividends

Clarity Pharmaceuticals Ltd
does not pay dividends
Shareholder Yield

Competitive Landscape

What is the Intrinsic Value of one CU6 stock?

The intrinsic value of one CU6 stock under the Base Case scenario is 0.6 AUD.

Is CU6 stock undervalued or overvalued?

Compared to the current market price of 3.08 AUD, Clarity Pharmaceuticals Ltd is Overvalued by 81%.

Back to Top